Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Aclaris Therapeutics

4.41
-0.8500-16.16%
Post-market: 4.460.0500+1.13%19:34 EDT
Volume:5.18M
Turnover:24.09M
Market Cap:649.15M
PE:-7.52
High:5.18
Open:5.18
Low:4.35
Close:5.26
52wk High:6.60
52wk Low:1.74
Shares:147.20M
Float Shares:101.00M
Volume Ratio:2.42
T/O Rate:5.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5861
EPS(LYR):-0.5300
ROE:-59.10%
ROA:-28.98%
PB:5.21
PE(LYR):-8.32

Loading ...

OverviewCompanyNewsFilings

Aclaris to release Phase 1a ATI-052 trial results April 28

Reuters
·
Apr 28

Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026

GlobeNewswire
·
Apr 28

Aclaris Therapeutics announces upcoming annual shareholder meeting

Reuters
·
Apr 23

Aclaris Therapeutics (ACRS) Gets a Buy from Craig-Hallum

TIPRANKS
·
Apr 17

Oppenheimer Initiates Aclaris Therapeutics at Outperform With $10 Price Target

MT Newswires Live
·
Apr 16

Aclaris Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $10

THOMSON REUTERS
·
Apr 16

Aclaris Therapeutics Initiated at Outperform by Oppenheimer

Dow Jones
·
Apr 16

U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial Services

Reuters
·
Apr 16

Cardiff Oncology names Mani Mohindru CEO, appoints Josh Muntner CFO

Reuters
·
Apr 10

Aclaris CEO to join fireside chat at H.C. Wainwright skin disease conference

Reuters
·
Apr 08

Analyst Rate

Buy
Buy
92.30%
Hold
7.69%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Pre-MKt
Financial Report Announcement
May 07, 2026 Pre-MKt
Financial Report Announcement
Feb 26, 2026 Pre-MKt
Financial Report Announcement
Nov 06, 2025 Pre-MKt
Financial Report Announcement
Aug 07, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-7.52
Current
-6.36
Sector Average
28.09%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-7.52
Maximum
-0.52
+1 STD
-1.71
Minimum
-15.53
-1 STD
-11.00
Average
-6.36

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.